BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37075652)

  • 21. Altered MANF and RYR2 concentrations associated with hypolipidemia in the serum of patients with schizophrenia.
    Xu K; Zheng P; Zhao S; Feng J; Pu J; Wang J; Zhao S; Wang H; Chen J; Xie P
    J Psychiatr Res; 2023 Jul; 163():142-149. PubMed ID: 37210832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal maternal immune disruption and sex-dependent risk for psychoses.
    Goldstein JM; Cherkerzian S; Seidman LJ; Donatelli JA; Remington AG; Tsuang MT; Hornig M; Buka SL
    Psychol Med; 2014 Nov; 44(15):3249-61. PubMed ID: 25065485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients.
    Yan J; Chen Y; Ju P; Gao J; Zhang L; Li J; Wang K; Zhang J; Li C; Xia Q; Zhu C; Zhang X
    Front Psychiatry; 2022; 13():834539. PubMed ID: 35273531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia.
    Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
    Mol Neurobiol; 2019 Oct; 56(10):7056-7073. PubMed ID: 30972627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia.
    Hope S; Dieset I; Agartz I; Steen NE; Ueland T; Melle I; Aukrust P; Andreassen OA
    J Psychiatr Res; 2011 Dec; 45(12):1608-16. PubMed ID: 21889167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.
    Halstead S; Siskind D; Amft M; Wagner E; Yakimov V; Shih-Jung Liu Z; Walder K; Warren N
    Lancet Psychiatry; 2023 Apr; 10(4):260-271. PubMed ID: 36863384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacterial Translocation Associates With Aggression in Schizophrenia Inpatients.
    Wang C; Zhang T; He L; Fu JY; Deng HX; Xue XL; Chen BT
    Front Syst Neurosci; 2021; 15():704069. PubMed ID: 34658801
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum zonulin and claudin-5 levels in patients with schizophrenia.
    Usta A; Kılıç F; Demirdaş A; Işık Ü; Doğuç DK; Bozkurt M
    Eur Arch Psychiatry Clin Neurosci; 2021 Jun; 271(4):767-773. PubMed ID: 32564127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep Disturbances and Inflammatory Biomarkers in Schizophrenia: Focus on Sex Differences.
    Lee EE; Ancoli-Israel S; Eyler LT; Tu XM; Palmer BW; Irwin MR; Jeste DV
    Am J Geriatr Psychiatry; 2019 Jan; 27(1):21-31. PubMed ID: 30442531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings.
    Noyan H; Erdağ E; Tüzün E; Yaylım İ; Küçükhüseyin Ö; Hakan MT; Gülöksüz S; Rutten BPF; Saka MC; Atbaşoğlu C; Alptekin K; van Os J; Üçok A
    Schizophr Res; 2021 Mar; 229():27-37. PubMed ID: 33609988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between inflammatory biomarkers and cognitive dysfunction in patients with schizophrenia: A systematic review and meta-analysis.
    Patlola SR; Donohoe G; McKernan DP
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110668. PubMed ID: 36283512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
    Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
    Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterising phospholipids and free fatty acids in patients with schizophrenia: A case-control study.
    Wang D; Sun X; Maziade M; Mao W; Zhang C; Wang J; Cao B
    World J Biol Psychiatry; 2021 Mar; 22(3):161-174. PubMed ID: 32677491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory biomarkers in psychosis and clinical high risk populations.
    Delaney S; Fallon B; Alaedini A; Yolken R; Indart A; Feng T; Wang Y; Javitt D
    Schizophr Res; 2019 Apr; 206():440-443. PubMed ID: 30414721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin converting enzyme activity is positively associated with IL-17a levels in patients with schizophrenia.
    Gadelha A; Yonamine CM; Nering M; Rizzo LB; Noto C; Cogo-Moreira H; Teixeira AL; Bressan R; Maes M; Brietzke E; Hayashi MA
    Psychiatry Res; 2015 Oct; 229(3):702-7. PubMed ID: 26296754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased IL-1β-induced CCL20 response in human iPSC-astrocytes in schizophrenia: Potential attenuating effects on recruitment of regulatory T cells.
    Akkouh IA; Ueland T; Hansson L; Inderhaug E; Hughes T; Steen NE; Aukrust P; Andreassen OA; Szabo A; Djurovic S
    Brain Behav Immun; 2020 Jul; 87():634-644. PubMed ID: 32109548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice.
    Zheng P; Zeng B; Liu M; Chen J; Pan J; Han Y; Liu Y; Cheng K; Zhou C; Wang H; Zhou X; Gui S; Perry SW; Wong ML; Licinio J; Wei H; Xie P
    Sci Adv; 2019 Feb; 5(2):eaau8317. PubMed ID: 30775438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype.
    Maes M; Kanchanatawan B; Sirivichayakul S; Carvalho AF
    Neurotox Res; 2019 Apr; 35(3):684-698. PubMed ID: 30552634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in executive function among patients with schizophrenia, their unaffected first-degree relatives and healthy participants.
    Kataoka Y; Shimada T; Koide Y; Okubo H; Uehara T; Shioiri T; Kawasaki Y; Ohi K
    Int J Neuropsychopharmacol; 2020 Jul; 23(11):731-7. PubMed ID: 32692837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of leaky gut-related markers as indicators of metabolic health in Dutch adults: The Nutrition Questionnaires plus (NQplus) study.
    Hoshiko H; Feskens EJM; Oosterink E; Ariens RMC; Mes JJ; de Wit NJW
    PLoS One; 2021; 16(6):e0252936. PubMed ID: 34086828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.